Ruihong Chen | Traditional Chinese Medicine | Best Researcher Award

Posted on by Best Paper Award

Dr. Ruihong Chen | Traditional Chinese Medicine | Best Researcher Award

Doctorate at Guangdong Medical University, China

Summary:

Dr. Chen is an Assistant Professor at the School of Medical Technology, Guangdong Medical University. He earned his Ph.D. in Traditional Chinese Medicine from Macau University of Science and Technology, where his research focused on the therapeutic effects of natural products from TCM on respiratory pathogens and cancer. Dr. Chen holds a Master’s degree in Pharmacology and a Bachelor’s degree in Pharmacy, both from Guangzhou Medical University. His research interests include natural small molecules, traditional Chinese medicine, and the development of agents for anticancer and anti-respiratory pathogen purposes. Dr. Chen has received several prestigious awards for his academic and research contributions.

Professional Profile:

👩‍🎓Education:

  • Ph.D. in Traditional Chinese Medicine
    Macau University of Science and Technology
    September 2019 – April 2023
  • Master of Science in Pharmacology
    Guangzhou Medical University
    September 2014 – June 2017

    • Awarded the National Scholarship for Master’s Students in 2017
  • Bachelor of Pharmacy
    Guangzhou Medical University
    September 2010 – June 2014

🏢 Professional Experience:

  • Assistant Professor
    School of Medical Technology, Guangdong Medical University
    June 2023 – Present
  • Research Assistant
    Affiliated Stomatology Hospital of Guangzhou Medical University
    June 2017 – June 2019

Research Interests:

Dr. Chen’s research focuses on the extraction, isolation, identification, and pharmacological effects of natural products from Traditional Chinese Medicine (TCM). His primary areas of interest include:

  • Discovery and development of drugs targeting anticancer and anti-respiratory pathogen applications.
  • Component analysis of natural products.
  • Exploration of pharmacological effects and elucidation of mechanisms of action.

Honors and Awards:

  • 2022: Macau Scientific and Technological Award for Postgraduates (Nomination)
  • 2017: National Scholarship for Postgraduates
  • 2017: Outstanding Graduate Student Award, Guangzhou Medical University
  • 2016: Outstanding Paper Award, Guangdong Pharmacists

Top Noted Publication:

“N-Acetylcysteine overcomes epalrestat-mediated increase of toxic 4-hydroxy-2-nonenal and potentiates the anti-arthritic effect of epalrestat in AIA model”

  • Authors: Wang, L., Huang, B., Zeng, Y., Chung, S.K., Wong, V.K.W.
  • Journal: International Journal of Biological Sciences
  • Year: 2023
  • Volume: 19
  • Issue: 13
  • Pages: 4082–4102
  • Citations: 2

“CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer”

  • Authors: Wang, J., Li, R.-Z., Wang, W.-J., He, J.-X., Leung, E.L.-H.
  • Journal: Pharmacological Research
  • Year: 2023
  • Volume: 194
  • Article Number: 106850
  • Citations: 4

“Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry”

  • Authors: Zhang, D., Hamdoun, S., Chen, R., Liu, L., Wong, V.K.W.
  • Journal: Pharmacological Research
  • Year: 2021
  • Volume: 172
  • Article Number: 105820
  • Citations: 56

“Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding”

  • Authors: Yang, L.J., Chen, R.H., Hamdoun, S., Law, B.Y.K., Wong, V.K.W.
  • Journal: Phytomedicine
  • Year: 2021
  • Volume: 87
  • Article Number: 153591
  • Citations: 44

“1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection”

  • Authors: Chen, R.H., Yang, L.J., Hamdoun, S., Law, B.Y.K., Wong, V.K.W.
  • Journal: Frontiers in Pharmacology
  • Year: 2021
  • Volume: 12
  • Article Number: 634176
  • Citations: 39